SciELO - Scientific Electronic Library Online

 
vol.32Preparación y evaluación de una vacuna aviar bivalente contra Newcastle y Salmonella, inactivada con formaldehído índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Artigo

Indicadores

  • Não possue artigos citadosCitado por SciELO

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Vaccimonitor

versão On-line ISSN 1025-0298

Resumo

RODRIGUEZ-PELIER, Cira et al. Levels of protection against Haemophilus influenzae type b in Cuban children, adolescents and adults. Vaccimonitor [online]. 2023, vol.32  Epub 01-Abr-2023. ISSN 1025-0298.

The levels of antibodies directed against the capsular polysaccharide polyribosylribitol phosphate of Haemophilus influenzae type b are considered a good serological indicator to assess the immunity against invasive disease. In Cuba, there are few reports that study serological immunity. The general objective was to determine serum protection levels against Haemophilus influenzae type b in Cuban children, adolescents and adults, in a sample of 575 Cuban individuals. The concentration of IgG against Haemophilus influenzae type b was quantified by means of an indirect ELISA standardized and validated in the immunology laboratory of the National Center of Medical Genetics, Havana, Cuba. The geometric mean concentration of IgG anti- polyribosylribitol phosphate and the levels of protection against invasive Haemophilus influenzae type b disease were determined. The geometric mean concentration of IgG anti- polyribosylribitol phosphate was 1.94 μg/mL (95%CI 1.80;2.08) and the group from 16 to 22 years old presented the highest. Among those with natural immunity, the percentage with long-term protection was higher for females vs. males (82.2% vs. 71.4%; p=0.0339). The group of subjects born in the period in which they were vaccinated with the Cuban conjugate vaccine QUIMI-HIB® presented higher geometric mean concentration (2.75 μg/mL, CI95% 2.00; 3.79). The 99.1% of the participants had protection against invasive Haemophilus influenzae type b disease, 19.8% short-term and 79.3% long-term protection. The ELISA for the quantification of anti- Haemophilus influenzae type b IgG antibodies, developed and validated, could be used in seroprevalence studies. In the subjects studied, there was a predominance of high IgG anti- Haemophilus influenzae type b polyribosylribitol phosphate concentration values that confer long-term protection.

Palavras-chave : validation study; Haemophilus influenzae type b; seroepidemiologic studies; immunoglobulin G; ELISA; Cuba.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )